Longevity Pulse
Academic PapersReviewsVideosPodcastsPress ReleasesClinical TrialsDrug ApprovalsTutorialsAnimations
All Articles
TutorialsClinical TutorialsVideosContinuous Listen
Free Subscription
Sign In
Deep Dive Audio
Personalized Immune Therapy Reduces Melanoma Recurrence After SurgeryCancer Research

Personalized Immune Therapy Reduces Melanoma Recurrence After Surgery

A personalized immune treatment helped keep high-risk melanoma from returning after surgery in a large randomized trial. Researchers assigned 1,137 patients to receive intismeran autogene or placebo, with both groups receiving pembrolizumab. After two years, 82.2% of patients receiving the combination were alive without cancer recurrence, compared with 70.0% receiving pembrolizumab plus placebo. Freedom from distant cancer spread was also higher, at 88.5% versus 80.2%. Benefits emerged after six months rather than immediately. Severe or worse adverse events occurred in 23.6% versus 20.3% of patients. Eight patients in the combination group died from adverse events, including five before receiving intismeran; this does not establish that intismeran caused those deaths. These findings support further clinical consideration, but longer overall survival remains unproven. This summary is based on the abstract only.

0:00--:--
Read Full Article
Longevity Pulse

Developed by the Clinical and Foundational Medicine Institute

AI-powered summaries of the world's best longevity research — from peer-reviewed journals to expert podcasts and YouTube deep-dives. Built for those who take their healthspan seriously.

info@LongevityToday.com

Categories

CancerHeart DiseaseAlzheimer'sParkinson'sDiabetesGut HealthNutritionStrength & FitnessSupplements & PeptidesStem CellsReversing AgingAuto-ImmunityAdvanced Therapies

Platform

  • All Articles
  • Membership Plans
  • Search
  • Newsletter

Newsletter

Weekly longevity research, summarized.

Enter your email to subscribe:

© 2026 Longevity Pulse. All rights reserved.

About UsPrivacy PolicyTerms of UseMedical Disclaimer

Content on Longevity Pulse is for informational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before making health decisions.